%0 Journal Article
%T Can we achieve complete remission in locally advanced unresectable Hepatocellular Carcinoma (HCC) by using Sorafenib? Case report and review of literature from Qatar
%A Kakil Ibrahim Rasul
%J Modern Chemotherapy
%P 1-4
%@ 2169-3498
%D 2012
%I Scientific Research Publishing
%R 10.4236/mc.2012.11001
%X Patients with HCC continue to have a dismal prognosis, with 1-year and 3-year survival rates of 36 and 17%, respectively. This is in part related to more than two-thirds of tumors being diagnosed at advanced stages, as well as a substantial portion of patients with early HCC failing to receive potentially curative treatments. Systemic therapy for advanced unresectable HCC limited until the discovery of sorafenib, we are reporting a 53 year patient with unresectable HCC achieved complete remission clinically, radiologically and biochemically with sorafenib which is the first case report.
%K Hepatocellular Ca
%K Sorafenib
%K Chemoembolization
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=21260